Allergan, the creator of Botox, is now part of AbbVie. Allergan plc is an American pharmaceutical company based in Ireland that specializes in the development, manufacture, and marketing of brand-name medicines and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company first became a public company through an initial public offering in 1977. In 1991, Allergan acquired Oculinum, a company that manufactured products for ocular muscle disorders. After the acquisition, the product was renamed Botox.
In 1996, Allergan received FDA approval for Alphagan ophthalmic solution for open-angle glaucoma and ocular hypertension. In 1998, Allergan established The Allergan Foundation, a private charitable foundation based in the United States. Auden Mckenzie Holdings Limited (Acq 201 Furiex Pharmaceuticals Inc (Acq 201 Procter & Gamble) (Prescription Drug Division, Acq 200 Specifar Pharmaceuticals S, A. were all acquired by Allergan.
Almost a year after the first announcement of the agreement between AbbVie and Allergan, the acquisition was completed. To ensure equitable access to all users, the SEC reserves the right to limit requests that originate from unreported automated tools. Your request has been identified as part of a network of automated tools outside of acceptable policy and will be handled until steps are taken to declare your traffic. Please declare your traffic by updating your user agent to include company specific information.
For more information, see the Privacy and Security Policy of the SEC website. By using this site, you agree to security monitoring and auditing. For security reasons, and to ensure that public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to cause damage, including attempts to deny service to users. To ensure that our website works well for all users, the SEC monitors the frequency of SEC and government content requests to ensure that automated searches do not affect the ability of others to access SEC and government content. We reserve the right to block IP addresses that send excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to send requests.
Please note that this policy may change as the SEC administers SEC.gov to ensure that the website functions efficiently and remains available to all users.
